Hepatobiliary Cancers, Version 2.2014
Al B. Benson(Northwestern University), Hema Sundar(National Comprehensive Cancer Network), Yun Yen(City Of Hope National Medical Center), Michael I. D’Angelica(Memorial Sloan Kettering Cancer Center), Steven G. Meranze(Vanderbilt University Medical Center), K Hoffmann(Leipzig University of Applied Sciences), Nicole R. McMillian, Robin Kate Kelley(UCSF Helen Diller Family Comprehensive Cancer Center), Elin R. Sigurdson(Fox Chase Cancer Center), Alan P. Venook(University of California, San Francisco), Mark Bloomston(The Ohio State University), Tracey E. Schefter(University of Colorado Anschutz Medical Campus), Thomas A. Abrams(Dana-Farber Cancer Institute), James O. Park(University of Washington Medical Center), Courtney L. Scaife(Huntsman Cancer Institute), Renuka Iyer(Roswell Park Comprehensive Cancer Center), Timothy M. Pawlik(The Ohio State University), G. Gary Tian, David C. Linehan(University of Rochester), Chandrakanth Are(Nebraska Medical Center), Daniel T. Chang(National Tsing Hua University), Jean‐Nicolas Vauthey(The University of Texas MD Anderson Cancer Center), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Anne M. Covey, William D. Ensminger, James Posey, Bryan M. Clary(University of San Diego), Mokenge P. Malafa(Moffitt Cancer Center)
Cited by 129
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k